EUVIMED · CrossrefZeitschrift
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
ISSN 2675-374X · Journal of Bone Marrow Transplantation and Cellular Therapy
Neueste Artikel
Insights of pediatric bone marrow transplantation in Brazil - A registry-based study (2018–2024)
Effectiveness of dose-intensified regimens in early progressed follicular lymphoma before autologous stem cell transplantation: A systematic review and meta-analysis
Hematopoietic cell transplantation outcomes in public centers in Brazil: analysis of the Brazilian Registry of Hematopoietic Cell Transplantation and Cellular Therapy, 2012–2024
EMERGING ACTIVITY OF CELLULAR IMMUNOTHERAPY FOR TREATMENT OF CANCER IN BRAZIL
Barriers to access of hematopoietic stem cell transplantation
COVID-19 AND HEMATOPOIETIC STEM CELL TRANSPLANTATION IN BRAZIL: ARE WE COPING?
COVID-19 and hematopoietic stem cell transplantation: recommendations from the Brazilian Society of Bone Marrow Transplantation (SBTMO)
Myelodysplastic Syndrome / Secondary Acute Myeloid Leukemia: role of the allogeneic hematopoietic stem cell transplantation
Evaluation of platelets transfusion in patients undergoing high dose chemotherapy for bone marrow transplantation
What is the role of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in the scenario of new drugs for Multiple Myeloma (MM)
Minimal residual disease in Acute Lymphoblastic Leukemia in the context of hematopoetic stem cell transplantation
Incidence of mucositis in patients undergoing autologous hematopoietic stem cell transplantation at a single center
Challenges and strategies used to increase the report of Brazilian Hematopoietic Stem Cell Transplantation (HSCT) data to the Center for International Blood and Marrow Transplant Research (CIBMTR)
Acute and chronic graft versus host disease after hematopoietic stem cell transplant
Analysis of Expansion Mesenchymal Stromal Cells in patients with low risk myelodysplastic syndrome
IMPRESSIONS ABOUT THE COVID-19 PANDEMIC AND BONE MARROW TRANSPLANTATION
COPING WITH THE COVID19 PANDEMIC IN A HEMATOLOGY, TRANSPLANTATION AND CELL THERAPY UNIT IN SOUTHERN BRAZlL
Nosso Desafio no Coração do Brasil
THE PANDEMIC SCENARIO AND BONE MARROW TRANSPLANTATION
ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?
THE EVOLVING LANDSCAPE OF ACUTE MYELOID LEUKEMIA TREATMENT
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ITS MAIN INDICATIONS: A SINGLE-CENTER, RETROSPECTIVE STUDY OF 30 YEARS
SARS-COV2 POSITIVE IN BONE MARROW TRANSPLANTATION SYMPTOMATIC PATIENTS: THE EXPERIENCE IN A SINGLE CENTER OF CEARA, BRAZIL
COVID-19 INFECTION IN A CANDIDATE FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT
INFLAMMATORY RESPONSE IN SOLID ORGAN AND TISSUE RECIPIENT WITH COVID-19
INCIDENCE AND RISK FACTORS FOR ORAL MUCOSITIS AFTER BONE MARROW TRANSPLANTATION PATIENTS UNDER LOW INTENSITY LASER THERAPY: A LONGITUDINAL STUDY
OVERVIEW OF THE BRAZILIAN OUTCOMES FROM FIRST MULTICENTRIC STUDY WITH USE FROM DATABASE CIBMTR. A PILOT STUDY.
COMPARATIVE ANALYSIS OF THE DATA ON THE INFLUENCE OF THE SARS-COV-2 PANDEMIC ON BONE MARROW TRANSPLANTATION AND THE PROTOCOLS ADOPTED IN BRAZIL BETWEEN MAY AND JUNE 2020
RECENT ADVANCES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR INHERITED BONE MARROW FAILURE SYNDROMES
Leucemia mielóide aguda em crianças e adolescentes em instituições Brasileiras: realidade e desafios
EUVIMED